Biohaven Quarterly Cash Flow Statement
NYSE: BHVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.08+0.15 (+1.26%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 12.02 -0.58%
Biohaven free cash flow
In the quarter ended Jun 30, 2026, Biohaven generated -$85.1 million of operating cash flow and spent $454,000 on capital expenditures. That left free cash flow of -$85.6 million.
Summary generated from market data by MetaCap's automated system. Methodology
Biohaven cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -137.31M | -130.53M | -145.56M | -173.44M | -198.15M | -221.68M | -186.84M | -160.30M | -319.77M | -179.50M | -144.76M | -102.57M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.26M | 2.37M | 2.57M | 3.13M | 1.98M | 2.25M | 2.46M | 1.99M | 1.95M | 1.45M | 1.89M | 1.54M |
| Stock-Based Compensation | 19.16M | 28.29M | 16.95M | 21.54M | 20.81M | 53.06M | 12.69M | 12.16M | 12.23M | 34.88M | 15.87M | 4.46M |
| Change in Working Capital | 9.21M | 11.34M | 2.97M | 4.36M | -3.04M | -7.15M | 6.62M | 15.69M | -30.00M | 16.44M | 4.81M | -13.38M |
| Operating Cash Flow | -85.10M | -149.92M | -130.66M | -145.72M | -167.94M | -165.12M | -170.74M | -141.28M | -167.80M | -102.64M | -114.88M | -94.81M |
| Capital Expenditures | -454.00K | 0 | -8.00K | -13.00K | -233.00K | -461.00K | -49.00K | -611.00K | -2.95M | -440.00K | -470.00K | -1.25M |
| Investing Cash Flow | 44.82M | 15.21M | -13.74M | 164.97M | -15.55M | 164.88M | -87.68M | -93.40M | -97.93M | 34.03M | -3.91M | 58.55M |
| Financing Cash Flow | 3.80M | 179.02M | 188.80M | 122.00K | 249.83M | 369.00K | 272.85M | 80.38M | 321.12M | 3.42M | 245.24M | -39.66M |
| Net Change in Cash | -36.48M | 44.33M | 44.40M | 19.39M | 66.31M | 147.00K | 14.52M | -154.30M | 55.39M | -65.19M | 126.13M | -75.96M |
| Free Cash Flow | -85.55M | -149.92M | -130.67M | -145.73M | -168.17M | -165.59M | -170.79M | -141.89M | -170.75M | -103.08M | -115.35M | -96.06M |
This table shows 12 quarterly periods of Biohaven's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BHVN's reporting calendar. What is a cash flow statement?